Crosstree Capital Partners Overview
- Service
-
Investment Bank
- Founded
-
2004
- Employees
-
34
- Serviced Companies
-
111
- Serviced Deals
-
104
- Serviced Investors
-
20
Crosstree Capital Partners General Information
Description
Founded in 2004, Crosstree Capital Partners is a Tampa, Florida-based healthcare-focused investment banking firm. The firm works with companies involved in global research and development, and the commercialization of biopharmaceutical, diagnostic, and digital healthcare products and services. Crosstree specializes in advising clients on mergers and acquisitions, liquidations, divestitures, recapitalizations, add-on acquisitions, and capital-raising deals.
Contact Information
Website
www.crosstreecapital.com
Year Founded
2004
Service Provider Type
Investment Bank
Primary Office
- 2701 North Rocky Point Drive
- Suite 925
- Tampa, FL 33607
- United States
+1 (813) 000-0000
Crosstree Capital Partners Services to Companies
Service on a Deal (104)
| Company Name | Service Provided | Deal Date | Deal Type | Deal Amount |
|---|---|---|---|---|
| Grenova | Advisor: Financial Due Diligence | Mar 2022 | 00000 | 0000000 |
| 000 000000000 | Advisor: General | Jan 2022 | 00000 | 0000000 |
| 00000000 00000000 | Advisor: General | Jan 2022 | 00000 | 0000000 |
| 000000 00000000000 | Advisor: General | Jan 2022 | 00000 | 0000000 |
| 000000000000000000 | Advisor: General | Dec 2021 | 00000 | 0000000 |
| 000000 00000000 00 | Advisor: General | Dec 2021 | 00000 | 0000000 |
| 00000000 00000 | Advisor: General | Dec 2021 | 00000 | 0000000 |
| 000000000 (0000000 | Advisor: General | Dec 2021 | 00000 | 0000000 |
| UpStream | Advisor: General | Nov 2021 | 00000 | 0000000 |
| Pharmica Consulting | Advisor: General | Oct 2021 | 00000 | 0000000 |
Crosstree Capital Partners Services to Investors
Service on a Deal — Buy Side (24)
| Investor Name | Service Provided | Deal Date | Deal Type | Deal Amount |
|---|---|---|---|---|
| Clinical Trials of Texas | Advisor: General | Jan 2022 | 00000 | 0000000 |
| 000 0000000000 000 | Advisor: General | Jan 2022 | 00000 | 0000000 |
| 0.0.0. 0000000 | Advisor: General | Dec 2021 | 00000 | 0000000 |
| 00000000 000000 00 | Advisor: General | Oct 2021 | 00000 | 0000000 |
| 000000 0000 | Advisor: General | Jul 2021 | 00000 | 0000000 |
| 00000000 | Advisor: General | Jun 2021 | 00000 | 0000000 |
| 000000000 | Advisor: General | Jun 2021 | 00000 | 0000000 |
| 000000000 | Advisor: General | Jun 2021 | 00000 | 0000000 |
| ArchiMed | Advisor: General | May 2021 | 00000 | 0000000 |
| dMed | Advisor: General | Apr 2021 | 00000 | 0000000 |
Service on a Deal — Sell Side (7)
| Investor Name | Service Provided | Deal Date | Deal Type | Deal Amount |
|---|---|---|---|---|
| GlaxoSmithKline | Advisor: General | Nov 2018 | 00000 | 0000000 |
| 000000 | Advisor: General | Oct 2018 | 00000 | 0000000 |
| 00000 00000 000000 | Advisor: General | Sep 2018 | 00000 | 0000000 |
| 0000000000 0000000 | Advisor: General | Aug 2018 | 00000 | 0000000 |
| 0000000000 0000000 | Advisor: General | Nov 2012 | 00000 | 0000000 |
| Enthalpy Analytical | Advisor: General | Jun 2010 | 00000 | 0000000 |
| Medifacts International | Advisor: General | Mar 2007 | 00000 | 0000000 |
Crosstree Capital Partners Investment Preferences
| Preferred Industries | Preferred Verticals | Preferred Deal Types | Geographic Preferences | Transaction Amount |
|---|